These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 22551731)

  • 1. Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients.
    Leite MI; Coutinho E; Lana-Peixoto M; Apostolos S; Waters P; Sato D; Melamud L; Marta M; Graham A; Spillane J; Villa AM; Callegaro D; Santos E; da Silva AM; Jarius S; Howard R; Nakashima I; Giovannoni G; Buckley C; Hilton-Jones D; Vincent A; Palace J
    Neurology; 2012 May; 78(20):1601-7. PubMed ID: 22551731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature.
    Jarius S; Paul F; Franciotta D; de Seze J; Münch C; Salvetti M; Ruprecht K; Liebetrau M; Wandinger KP; Akman-Demir G; Melms A; Kristoferitsch W; Wildemann B
    Mult Scler; 2012 Aug; 18(8):1135-43. PubMed ID: 22183934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature.
    Ikeguchi R; Shimizu Y; Suzuki S; Shimizu S; Kabasawa C; Hashimoto S; Masuda M; Nagane Y; Utsugisawa K; Suzuki Y; Takahashi T; Utsumi H; Fujihara K; Suzuki N; Uchiyama S
    Clin Neurol Neurosurg; 2014 Oct; 125():217-21. PubMed ID: 25178916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
    Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
    JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transverse myelitis syndrom as a result of neuromyelitis optica spectrum disorders, systemic lupus erythematosus and myasthenia gravis combination].
    Topuzova MP; Bisaga GN; Alekseeva TM; Isabekova PS; Сhaykovskaya AD; Panina EB; Pavlova TA; Ternovykh IK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(7. Vyp. 2):97-106. PubMed ID: 32844638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: A multicenter cohort study.
    Kessler RA; Mealy MA; Jimenez-Arango JA; Quan C; Paul F; López R; Hopkins S; Levy M
    Mult Scler Relat Disord; 2017 Oct; 17():198-201. PubMed ID: 29055457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromyelitis optica spectrum disorder presenting with concurrent autoimmune diseases.
    Bibic VC; Brust TB; Burton JM
    Mult Scler Relat Disord; 2019 Feb; 28():125-128. PubMed ID: 30593981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between severe attacks and serum aquaporin-4 antibody titer in neuromyelitis optica spectrum disorder.
    Wang R; Sun D; Wang X; Shi Z; Kong L; Du Q; Zhang Y; Chen H; Luo W; Zhang N; Zhou H
    J Neurol; 2024 Jul; 271(7):4503-4512. PubMed ID: 38703259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromyelitis optica in patients with myasthenia gravis: Two case-reports.
    Castro-Suarez S; Guevara-Silva E; Caparó-Zamalloa C; Cortez J; Meza-Vega M
    Mult Scler Relat Disord; 2020 Aug; 43():102173. PubMed ID: 32442888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
    Fan S; Xu Y; Ren H; Guan H; Feng F; Gao X; Ding D; Fang F; Shan G; Guan T; Zhang Y; Dai Y; Yao M; Peng B; Zhu Y; Cui L
    Mult Scler Relat Disord; 2018 Feb; 20():144-152. PubMed ID: 29414288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-MOG and Anti-AQP4 positive neuromyelitis optica spectrum disorder in a patient with myasthenia gravis.
    Bates M; Chisholm J; Miller E; Avasarala J; Guduru Z
    Mult Scler Relat Disord; 2020 Sep; 44():102205. PubMed ID: 32526697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-aquaporin-4 antibody-positive definite neuromyelitis optica in a patient with thymectomy for myasthenia gravis.
    Ogaki K; Hirayama T; Chijiiwa K; Fukae J; Furuya T; Noda K; Fujishima K; Hattori N; Takahashi T; Okuma Y
    Neurologist; 2012 Mar; 18(2):76-9. PubMed ID: 22367834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
    Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
    JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymoma-associated myasthenia gravis: Clinical features and predictive value of antiacetylcholine receptor antibodies in the risk of recurrence of thymoma.
    De Rosa A; Fornili M; Maestri Tassoni M; Guida M; Baglietto L; Petrucci L; Chella A; Melfi F; Lucchi M; Ricciardi R
    Thorac Cancer; 2021 Jan; 12(1):106-113. PubMed ID: 33142021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies.
    Chang X; Huang W; Wang L; ZhangBao J; Zhou L; Lu C; Wang M; Yu J; Li H; Li Y; Zhao C; Lu J; Quan C
    Front Immunol; 2021; 12():647618. PubMed ID: 33796113
    [No Abstract]   [Full Text] [Related]  

  • 17. Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder.
    Ungureanu A; de Seze J; Ahle G; Sellal F
    Rev Neurol (Paris); 2018 Dec; 174(10):675-679. PubMed ID: 30293882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aquaporin-4 antibodies are not related to HTLV-1 associated myelopathy.
    von Glehn F; Jarius S; Penalva de Oliveira AC; Brandão CO; Farias AS; Damasceno A; Casseb J; Moraes AS; Longhini AL; Wandinger KP; Damasceno BP; Wildemann B; Santos LM
    PLoS One; 2012; 7(7):e39372. PubMed ID: 22808032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
    J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
    Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
    Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.